Despite promising preliminary results in treating fibromyalgia (FM) pain, no neuromodulation technique has been adopted in clinical practice due to limited efficacy, low response rate, or poor tolerability. This Phase II open-label trial aims to define methodology for a clinically effective treatment of pain in FM by establishing treatment protocols and screening procedures to maximize efficacy and response rate. High-Definition transcranial Direct Current Stimulation (HD-tDCS) provides targeted sub-threshold brain stimulation, combining tolerability with specificity.
from The Journal of Pain http://ift.tt/1FTFitz
via IFTTT
No comments:
Post a Comment